FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021016777> ?p ?o ?g. }

• W2021016777 endingPage "472" @default.
• W2021016777 startingPage "469" @default.
• W2021016777 abstract "The ultimate treatment for severe short bowel syndrome is small bowel transplantation (SBT). Current immunosuppression for SBT is relatively ineffective and toxic. Peptides derived from residues 75-84 of the HLA-B7 molecule are immunomodulatory in vitro, and in rodents, when combined with subtherapeutic doses of cyclosporine (CsA), prolong cardiac and skin allograft survival without altering the recipient's rejection kinetics to third party allografts. We investigated the effects of HLA-B7 peptide fragment in a rat model of SBT.Heterotopic allogeneic SBT was performed in Dagouti (RT1a) to Lewis (RT1l) high-responder rat strain combination. B7.75-84 (40 mg/kg/d) and subtherapeutic CsA (10 mg/kg/d) were administered alone, or in combination, by gavage to allograft recipients on days 0 to 4 after SBT. Recipient pretreatment with B7.75-84 on days -14, -12, -10, and -7 followed by subtherapeutic CsA on days 0 to 4 after SBT was also carried out. Graft rejection was determined by the presence of a palpable abdominal mass on daily examination or by loss of more than 10% initial body weight.Without immunosuppression allografts rejected at a median time of 6 days (range, 5 to 7; n = 7). This was not significantly altered with either CsA therapy alone (median 6 days; range, 6 to 7; n = 6) or B7.75-84 alone (median, 5 days; range, 5 to 6; n = 6). Recipient combination therapy with B7.75-84 and CsA after allografting significantly prolonged allograft survival (median, 11 days; range, 9 to 13; n = 9), as did recipient B7.75-84 pretransplant therapy (median, 10 days; range, 9 to 12; n = 6), when administered over a 2-week period before allografting.Post-SBT recipient treatment with B7.75-84 produced statistically significant improvement in allograft survival only after combination with subtherapeutic CsA. Recipient pre-SBT treatment with B7.75-84 alone however, resulted in statistically significant improvement in allograft survival in combination with post-SBT subtherapeutic CsA. These synergistic effects may be valuable in achieving improved SBT survival clinically and warrant further exploration." @default.
• W2021016777 created "2016-06-24" @default.
• W2021016777 creator A5020047087 @default.
• W2021016777 creator A5022269634 @default.
• W2021016777 creator A5051756444 @default.
• W2021016777 creator A5086351179 @default.
• W2021016777 date "1997-03-01" @default.
• W2021016777 modified "2023-10-14" @default.
• W2021016777 title "Treatment with an HLA-peptide and cyclosporine a prolongs rat small bowel allograft surgival" @default.
• W2021016777 cites W1760373952 @default.
• W2021016777 cites W1968202502 @default.
• W2021016777 cites W1969971113 @default.
• W2021016777 cites W1973852930 @default.
• W2021016777 cites W1976201342 @default.
• W2021016777 cites W1999477551 @default.
• W2021016777 cites W2019231667 @default.
• W2021016777 cites W2023256291 @default.
• W2021016777 cites W2036039626 @default.
• W2021016777 cites W2045096857 @default.
• W2021016777 cites W2077919419 @default.
• W2021016777 cites W2082535269 @default.
• W2021016777 cites W2099305021 @default.
• W2021016777 cites W2117280686 @default.
• W2021016777 cites W2315888271 @default.
• W2021016777 doi "https://doi.org/10.1016/s0022-3468(97)90608-4" @default.
• W2021016777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9094020" @default.
• W2021016777 hasPublicationYear "1997" @default.
• W2021016777 type Work @default.
• W2021016777 sameAs 2021016777 @default.
• W2021016777 citedByCount "10" @default.
• W2021016777 crossrefType "journal-article" @default.
• W2021016777 hasAuthorship W2021016777A5020047087 @default.
• W2021016777 hasAuthorship W2021016777A5022269634 @default.
• W2021016777 hasAuthorship W2021016777A5051756444 @default.
• W2021016777 hasAuthorship W2021016777A5086351179 @default.
• W2021016777 hasConcept C126322002 @default.
• W2021016777 hasConcept C126894567 @default.
• W2021016777 hasConcept C141071460 @default.
• W2021016777 hasConcept C203014093 @default.
• W2021016777 hasConcept C2780252810 @default.
• W2021016777 hasConcept C2911091166 @default.
• W2021016777 hasConcept C71924100 @default.
• W2021016777 hasConcept C90924648 @default.
• W2021016777 hasConceptScore W2021016777C126322002 @default.
• W2021016777 hasConceptScore W2021016777C126894567 @default.
• W2021016777 hasConceptScore W2021016777C141071460 @default.
• W2021016777 hasConceptScore W2021016777C203014093 @default.
• W2021016777 hasConceptScore W2021016777C2780252810 @default.
• W2021016777 hasConceptScore W2021016777C2911091166 @default.
• W2021016777 hasConceptScore W2021016777C71924100 @default.
• W2021016777 hasConceptScore W2021016777C90924648 @default.
• W2021016777 hasIssue "3" @default.
• W2021016777 hasLocation W20210167771 @default.
• W2021016777 hasLocation W20210167772 @default.
• W2021016777 hasOpenAccess W2021016777 @default.
• W2021016777 hasPrimaryLocation W20210167771 @default.
• W2021016777 hasRelatedWork W2034212555 @default.
• W2021016777 hasRelatedWork W2040903658 @default.
• W2021016777 hasRelatedWork W2061396063 @default.
• W2021016777 hasRelatedWork W2356894405 @default.
• W2021016777 hasRelatedWork W2410991317 @default.
• W2021016777 hasRelatedWork W2418946042 @default.
• W2021016777 hasRelatedWork W2497092908 @default.
• W2021016777 hasRelatedWork W3149337076 @default.
• W2021016777 hasRelatedWork W4320041232 @default.
• W2021016777 hasRelatedWork W4386893802 @default.
• W2021016777 hasVolume "32" @default.
• W2021016777 isParatext "false" @default.
• W2021016777 isRetracted "false" @default.
• W2021016777 magId "2021016777" @default.
• W2021016777 workType "article" @default.